1. Wang, Liangliang, Dou, Xiaoyang, Chen, Shijie, He, Chuan, Weichselbaum, Ralph R. 2023. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. In Cancer cell, 41, 1294-1308.e8. doi:10.1016/j.ccell.2023.04.019. https://pubmed.ncbi.nlm.nih.gov/37236197/
2. Tanabe, Atsushi, Nakayama, Takatoshi, Kashiyanagi, Jo, Takemasa, Ichiro, Sahara, Hiroeki. 2022. YTHDC2 Promotes Malignant Phenotypes of Breast Cancer Cells. In Journal of oncology, 2022, 9188920. doi:10.1155/2022/9188920. https://pubmed.ncbi.nlm.nih.gov/36245989/
3. Qian, Baomei, Li, Yang, Yan, Ruoyu, Zhou, Jian, Ye, Lan. 2022. RNA binding protein RBM46 regulates mitotic-to-meiotic transition in spermatogenesis. In Science advances, 8, eabq2945. doi:10.1126/sciadv.abq2945. https://pubmed.ncbi.nlm.nih.gov/36001654/
4. Bailey, Alexis S, Fuller, Margaret T. 2024. YTHDC2 serves a distinct late role in spermatocytes during germ cell differentiation. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2309548121. doi:10.1073/pnas.2309548121. https://pubmed.ncbi.nlm.nih.gov/39378093/
5. Zhou, Bing, Liu, Caizhi, Xu, Lingyan, Lu, Yan, Ma, Xinran. 2020. N6 -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes. In Hepatology (Baltimore, Md.), 73, 91-103. doi:10.1002/hep.31220. https://pubmed.ncbi.nlm.nih.gov/32150756/